SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-133298
Filing Date
2016-11-10
Accepted
2016-11-10 16:15:57
Documents
2
Period of Report
2016-11-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v452766_8k.htm 8-K 21850
2 EXHIBIT 3.01(I) v452766_ex3-01i.htm EX-3.01(I) 14651
  Complete submission text file 0001144204-16-133298.txt   37760
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 161988232
SIC: 2834 Pharmaceutical Preparations